Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nystatin 250mg capsules
0502030B0AAAKAK
|
Nystatin (Systemic) | Nystatin | Infections | No data available |
|
Nystatin 500,000unit tablets
0502030B0AAAIAI
|
Nystatin (Systemic) | Nystatin | Infections | No data available |
|
Nystatin powder
0502030B0AAACAC
|
Nystatin (Systemic) | Nystatin | Infections | No data available |
|
Ofloxacin 100mg/5ml oral liquid
0501120P0AAADAD
|
Ofloxacin (Systemic) | Ofloxacin | Infections | No data available |
|
Ofloxacin 200mg/100ml solution for infusion bottles
0501120P0AAACAC
|
Ofloxacin (Systemic) | Ofloxacin | Infections | No data available |
|
Ofloxacin 250mg/5ml oral liquid
0501120P0AAAEAE
|
Ofloxacin (Systemic) | Ofloxacin | Infections | No data available |
|
Olysio 150mg capsules
0503032D0BBAAAA
|
Olysio | Simeprevir | Infections | No data available |
|
Orelox 100mg tablets
0501021F0BBAAAA
|
Orelox | Cefpodoxime | Infections | No data available |
|
Orelox 40mg/5ml oral suspension paediatric
0501021F0BBABAB
|
Orelox | Cefpodoxime | Infections | No data available |
|
Oseltamivir 15mg/ml oral liquid
0503040B0AAAEAE
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | No data available |
|
Oseltamivir 15mg/ml oral solution sugar free
0503040B0AAAFAF
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | No data available |
|
Oseltamivir 60mg/5ml oral suspension sugar free
0503040B0AAABAB
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | No data available |
|
Oxymycin 250mg tablets
0501030T0BFAAAJ
|
Oxymycin | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 100mg/5ml oral suspension
0501030T0AAATAT
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 125mg/5ml oral suspension
0501030T0AAAPAP
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 250mg/5ml oral suspension
0501030T0AAAQAQ
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 500mg/5ml oral suspension
0501030T0AAARAR
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetramix 250 tablets
0501030T0BIAAAJ
|
Oxytetramix-250 | Oxytetracycline | Infections | No data available |
|
Palivizumab 100mg inj vials
0503050A0AAAAAA
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 100mg/1ml solution for injection vials
0503050A0AAADAD
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 50mg inj vials
0503050A0AAABAB
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 50mg/0.5ml solution for injection vials
0503050A0AAACAC
|
Palivizumab | Palivizumab | Infections | No data available |
|
Paludrine 100mg tablets
0504010M0BBAAAA
|
Paludrine | Proguanil hydrochloride | Infections | No data available |
|
Paludrine/Avloclor tablets anti-malarial travel pack
0504010Z0BBAAAA
|
Paludrine/avloclor | Chloroquine phosphate with proguanil hydrochloride | Infections | No data available |
|
Paromomycin 125mg/5ml oral solution
0504050T0AAACAC
|
Paromomycin sulfate | Paromomycin sulfate | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.